ICICI Securities maintains an Add call on Apollo Hospitals Enterprise, raising the target price to Rs 7,500. This revision reflects anticipated faster growth and improved margins in the pharmacy sector. The brokerage has increased revenue, EBITDA, and PAT estimates for FY26 and FY27, valuing the hospital business at 25x FY27E EV/EBITDA.
Positive Breakout: These 6 stocks cross above their 200 DMAs
In the Nifty500 pack, six stocks’ closing prices crossed above their 200-day moving averages (DMA) on October 30, 2026, according to StockEdge’s technical scan data.